We are excited to announce that Abingdon Health have completed the Technical Transfer of our KnowNow (Spike Test USA) rapid COVID-19 test. This marks the completion of the scale-up of our manufacturing process to begin to fulfil global pre-orders of our unique testing technology. It has been a long and rewarding journey from technology validation to manufacturing scale up, and we are excited to begin releasing tests to market. As a UK start-up it has been a pleasure to work with a UK-based manufacturing company to deliver our next generation of COVID-19 tests, and we are excited to see where this partnership takes us beyond COVID-19.
Dr Mona K. Omir, CTO of Vatic Health Limited, commented:
“Completing the Technical Transfer of the KnowNow test is a huge milestone in the Vatic Health journey and our ongoing collaboration with Abingdon Health. To bring such novel assay technology into routine manufacturing could be a true step change in diagnostics and we are excited for what this could mean for COVID-19 testing around the world.”
Devices will be available for sale in the EU (Professional Use currently) from May (subject to local legislation). The test is CE Marked in Europe for professional use via our competent authority (Halmed, Croatia) and is also listed on the European list of tests: https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/2508
Get in touch by submitting the enquiry form found below…
The full Abingdon Health press release can be found here.
Register interest to find out more about our saliva based COVID-19 test.